DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce
bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a
drug used in patients with bleeding disorders. It works by activating molecules in the blood
stream called platelets that promote clotting. In the study, participants who are have
cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive
medication. Photographs taken before and shortly after surgery will be evaluated for the
amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not
eligible to participate.